COMMUNIQUÉS West-GlobeNewswire

PharmAla Biotech Provides Corporate Update: Change of Auditor, Retention of Watertower Research and Oak Hill
17/09/2026
TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
17/09/2026
– Late-Breaking Data to Include HOPE-3 Delayed-Start and Natural History Analyses Submitted in the Recent Major Amendment to the Deramiocel BLA – – PDUFA Target Action Date of November 22, 2026 – SAN DIEGO, Sept. 17, [...]
Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome
17/09/2026
Last patient has completed the last scheduled study visit in the pivotal Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome Top-line results remain on track for late November 2026 NESS ZIONA, [...]
TOMI’s SteraMist Integrated System (SIS) Strategy Converts to Orders: Enclosure Sales Reach $2.3 Million YTD
17/09/2026
Standardized SIS Selling Packages Accelerate Closings and Retrofits, with Recent Purchase Orders slated for Q3-Q4 revenue recognition. SteraBox aimed at recycling, electronics refurbishment, and circular-economy use. [...]
Commure Named to TIME's World’s Top HealthTech Companies for Second Consecutive Year
17/09/2026
In the AI & Data Analytics category, Commure earned recognition for outstanding performance MOUNTAIN VIEW, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today [...]
Novo: CHMP recommends EU approval of FREHEMGO® (denecimig), the first factor VIIIa mimetic offering monthly, once every two weeks and weekly dosing in a pre-filled pen, for the treatment of haemophilia A
17/09/2026
FREHEMGO® (denecimig) has been recommended by CHMP for approval in the EU for the treatment of haemophilia A (congenital FVIII deficiency), with or without inhibitors for adults and children FREHEMGO® is the first [...]
Live Oaks Wellness Addiction Treatment Facility Strengthens Marin County Recovery Community through Outreach, Education and Service
17/09/2026
Recent ‘Recover or Die’ Charity Event Raises Awareness for Substance Addiction NOVATO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- When it comes to increasing responsible conversation around addiction and reducing the [...]
San Diego-based Shoreline Recovery Center Encourages Compassionate Support for those Struggling with Addiction
17/09/2026
From Overdose Awareness to Recovery San Diego, CA., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Overdose is a common and serious risk for individuals with a substance use disorder. It is also preventable, with the simple act of [...]
San Diego-based Park Mental Health Treatment Facility Highlights Importance of Mental Wellness Recognized as Year-Round Healthcare Priority
17/09/2026
Mental Wellness Requires Preventive Approach, Too San Diego, CA., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Each year, specific months are dedicated to bringing awareness to various mental health topics; depression, PTSD, [...]
LQpay Introduces Custom AI Assistant LuQ, Bringing AI Directly into the Healthcare Payments Experience
17/09/2026
LuQ marks the first step in LQpay’s broader strategy to leverage AI and emerging technologies to simplify workflows, enhance automation and help healthcare organizations work more efficiently PLANTATION, Fla., Sept. 17 [...]
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement
17/09/2026
Combined company to focus on developing first-in-class next-generation medicines for cardioendocrine diseases Marea has multiple late-stage clinical product candidates: MAR001/005 for severe hypertriglyceridemia (sHTG) [...]
TimelyCare Unveils "Connected Care for Every Student," with an AI Well-being Guide as an Easier First Step
17/09/2026
Built for every student, including those who would never book an appointment, the model pairs an AI well-being guide with human coaching and licensed clinical care. Fort Worth, TX, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
Fifteen Students Living With IBD Receive Scholarships to Help Pursue Their Education
17/09/2026
The AbbVie IBD Scholarship Program marks 15 years of recognizing the resilience and ambitions of students across Canada living with Crohn’s disease or ulcerative colitis TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Crohn [...]
Quinze étudiants atteints d’une MII reçoivent des bourses pour poursuivre leurs études
17/09/2026
Le programme de bourses d’études MII d’AbbVie souligne 15 ans de reconnaissance de la résilience et des ambitions des étudiants qui vivent avec la maladie de Crohn ou la colite ulcéreuse à travers le Canada TORONTO, 17 [...]
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
17/09/2026
SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today [...]
Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
17/09/2026
New Filing Seeks Broad Protection Around Creative Medical’s Cell-Free Regenerative Platform, Including Product Composition, Functional Potency, Manufacturing Controls and Additional Therapeutic Applications PHOENIX, [...]
Wandercraft Launches Eve™, the World’s First Self-Balancing Personal Exoskeleton, Bringing Hands-Free Upright Mobility to the Home
17/09/2026
FDA-cleared Eve is now commercially available in the U.S. to eligible adults with spinal cord injuries at any level, supported by a growing network for evaluation, training, reimbursement, delivery, and service NEW YORK [...]
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
17/09/2026
Chief Commercial Officer Bryan Downey Joins Panel Discussion on Reinventing the Launch Playbook for Small and Mid-Size Pharma KANSAS CITY, Kan., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a [...]
Recludix Pharma to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
17/09/2026
SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy [...]

Pages